ARCHIVES

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Gerald Murphy To Leave Cancer Society Sept. 1 To Direct Foundation

April 23, 1993

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

Carbone Heads Chairmen’s Group

June 30, 1978

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

March 19, 1999

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003

NIH Draft Guidelines On Stem Cell Research Limit Funds To Cells From In Vitro Fertilization

April 24, 2009